MEK-Ing progress in low-grade serous ovarian cancer. Gershenson DM. Gynecol Oncol 2026;213:A1-A3.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gershenson DM. MEK-Ing progress in low-grade serous ovarian cancer. Gynecol Oncol 2026;213:A1-A3.
PMID: 42919489